{
  "schemaVersion": 1,
  "id": "research-218",
  "slug": "218-why-weight-and-vomiting-were-separate-outcomes-in-a-ferret-experiment",
  "title": "Why weight and vomiting were separate outcomes in a ferret experiment",
  "catalogLabel": "Ipamorelin",
  "productCollection": "https://heritagebiolabs.com/research-library/products/ipamorelin",
  "productHandles": [
    "ipamorelin-684",
    "ipamorelin-483",
    "ipamorelin-589",
    "ipamorelin-590"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/ipamorelin-684",
    "https://heritagebiolabs.com/product/ipamorelin-483",
    "https://heritagebiolabs.com/product/ipamorelin-589",
    "https://heritagebiolabs.com/product/ipamorelin-590"
  ],
  "readingFocus": "Interpreting evidence",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 257,
  "sourceYears": [
    2024
  ],
  "paragraphs": [
    "Peptides are short chains of amino acids joined by peptide bonds. Some act on receptors involved in feeding and digestive function. Ipamorelin is a synthetic five-residue peptide that activates the ghrelin receptor, also called the growth hormone secretagogue receptor. A study in ferrets asked whether this signal affected weight change and vomiting after exposure to a chemotherapy drug. [1, 2]",
    "No recent primary study repeating the exact animal comparison was identified. In the older 2024 experiment, researchers studied ferrets exposed to cisplatin, a drug that can cause vomiting and reduced food intake. They compared ipamorelin, a different ghrelin-receptor agonist called anamorelin, and a control condition. They measured food and water consumption, weight change and episodes of vomiting. They also compared the compounds in an isolated section of ferret intestine. [1]",
    "In the comparison that included ipamorelin, the investigators saw less weight loss late in the observation window but did not detect a change in vomiting. In a separate experiment they observed a change in early vomiting after administering anamorelin in a way that tested a central effect. That observation involved anamorelin, a distinct compound, and cannot be assigned to ipamorelin. [1]",
    "The older study shows why the effects of two receptor agonists should be attributed to their specific compounds and endpoints. A difference in weight over several days can occur without a change in vomiting, and it does not establish a change in long-term body composition. These were animal findings with a particular chemotherapy exposure. They do not show that ipamorelin helps people receiving chemotherapy. [1, 2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Lu Z et al. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Physiology & Behavior (publication 2024-07-21).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/39043357/"
    },
    {
      "number": 2,
      "citation": "U.S. Food and Drug Administration. October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee. FDA briefing document on ipamorelin-related bulk drug substances (publication 2024-10-29).",
      "url": "https://www.fda.gov/media/182088/download"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/218-why-weight-and-vomiting-were-separate-outcomes-in-a-ferret-experiment",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/218-why-weight-and-vomiting-were-separate-outcomes-in-a-ferret-experiment.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/218-why-weight-and-vomiting-were-separate-outcomes-in-a-ferret-experiment.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 044 - IGF-LR3 and Ipamorelin.docx",
    "sourceArticleNumber": 218,
    "contentSha256": "3fe251a71187e316757af019a699c2f29ca35672b6a20c8d34be1e344d92c446",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
